The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $23.97

Today's change+0.20 +0.84%
Updated August 26 4:01 PM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $23.97

Today's change+0.20 +0.84%
Updated August 26 4:01 PM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp up (U.S.)$0.20

Boston Scientific Corp closed up Friday by (U.S.)$0.20 or 0.84% to (U.S.)$23.97. Shares have lost 0.83% over the last five days, but sit 3.31% below their 52-week high. This security has outperformed the S&P 500 by 34.65% during the last year.

Key company metrics

  • Open(U.S.) $23.85
  • Previous close(U.S.) $23.77
  • High(U.S.) $24.04
  • Low(U.S.) $23.70
  • Bid / Ask-- / --
  • YTD % change+29.99%
  • Volume6,744,311
  • Average volume (10-day)5,362,841
  • Average volume (1-month)7,429,637
  • Average volume (3-month)10,321,882
  • 52-week range(U.S.) $15.67 to (U.S.) $24.79
  • Beta0.99
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward21.79×
  • Forward PEG1.67×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.26
Updated August 26 4:01 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue2,1261,9641,9781,888
Total other revenue--------
Total revenue2,1261,9641,9781,888
Gross profit1,4941,3961,4161,354
Total cost of revenue632568562534
Total operating expense2,4601,6712,2492,187
Selling / general / administrative774711774720
Research & development222210244221
Depreciation / amortization135136134131
Interest expense (income), net operating--------
Unusual expense (income)67727518564
Other operating expenses, total20191717
Operating income-334293-271-299
Interest income (expense), net non-operating-59-59-59-58
Gain (loss) on sale of assets--------
Other--------
Income before tax-397228-338-367
Income after tax-207202-142-198
Income tax, total-19026-196-169
Net income-207202-142-198
Total adjustments to net income--------
Net income before extra. items-207202-142-198
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-207202-142-198
Inc. avail. to common incl. extra. items-207202-142-198
Diluted net income-207202-142-198
Dilution adjustment--------
Diluted weighted average shares1,3571,3701,3461,344
Diluted EPS excluding extraordinary itemsvalue per share-0.150.15-0.11-0.15
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.170.160.140.13